These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations. Chen K, Pleasants KA, Pleasants RA, Beiko T, Washburn RG, Yu Z, Zhai S, Drummond MB. COPD; 2020 Jun; 17(3):311-317. PubMed ID: 32456479 [Abstract] [Full Text] [Related]
25. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model. Canut A, Martín-Herrero JE, Labora A, Maortua H. J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285 [Abstract] [Full Text] [Related]
27. Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease. Wang H, Gu X, Weng Y, Xu T, Fu Z, Peng W, Yu W. BMC Pulm Med; 2015 Aug 19; 15():94. PubMed ID: 26286268 [Abstract] [Full Text] [Related]
28. Impact of diurnal temperature variations on sputum bacterial detection in hospitalized patients with acute COPD exacerbation: a retrospective study from Fuzhou, China. Xue H, Xue Q, Wang C, Chen Q, Wang D, Li Z, Xie B, Zheng W. BMC Pulm Med; 2024 Jun 22; 24(1):291. PubMed ID: 38909192 [Abstract] [Full Text] [Related]
31. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics? Miravitlles M, Anzueto A. Int J Mol Sci; 2017 Jun 23; 18(7):. PubMed ID: 28644389 [Abstract] [Full Text] [Related]
32. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R. Clin Infect Dis; 2004 Oct 01; 39(7):980-6. PubMed ID: 15472849 [Abstract] [Full Text] [Related]
34. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A. Crit Care Med; 2006 Dec 01; 34(12):2959-66. PubMed ID: 17012911 [Abstract] [Full Text] [Related]
35. Bacterial etiology in early re-admission patients with acute exacerbation of chronic obstructive pulmonary disease. Lin J, He SS, Xu YZ, Li HY, Wu XM, Feng JX. Afr Health Sci; 2019 Jun 01; 19(2):2073-2081. PubMed ID: 31656491 [Abstract] [Full Text] [Related]
38. Detection and identification of bacterial pathogens directly from sputum samples by pyrosequencing. Lyu J, Zhang J, Ren X. J Med Microbiol; 2019 Mar 01; 68(3):368-373. PubMed ID: 30632958 [Abstract] [Full Text] [Related]
39. [Not all exacerbations of chronic obstructive pulmonary disease should be treated with antibiotics]. Nielsen SK, Lange P. Ugeskr Laeger; 2017 Apr 10; 179(15):. PubMed ID: 29332624 [Abstract] [Full Text] [Related]